HOUSTON, April 07, 2016 -- Synthesis Energy Systems, Inc. (SES) (NASDAQ:SYMX), the global leader of full-range feedstock flexibility in advanced energy gasification technology, producing clean and economical syngas to replace expensive imported natural gas and LNG based energy, announced that Senior Vice President and Chief Technology Officer Francis Lau will present at the World Coal-To-X (CTX) 2016 Conference in Beijing on Wednesday, April 13, 2:00 p.m. CST. Mr. Lau will present an SES Gasification Technology (SGT) overview and provide an update on the cleaner coal-to-syngas operations, projects, and the economic and environmental benefits of SGT.
Mr. Lau joined SES in September 2008 and is responsible for technology commercialization and continued development. Previously, Mr. Lau was the Executive Director of Gasification and Gas Processing Center at the Gas Technology Institute (GTI), where he led R&D, demonstration, and deployment programs aimed at the clean, efficient conversion of coal, biomass, and other feedstocks to substitute natural gas, electricity, hydrogen, and clean liquid fuels. He was involved in the development of several gasification and related technologies. Mr. Lau has published numerous papers on energy topics and holds several patents on energy conversion systems. He won the 2003 Pitt Award for his contributions to coal conversion R&D. Mr. Lau has a B.S. in Chemical Engineering from the University of Wisconsin, and a M.S. in Chemical Engineering from Northwestern University. He is fluent in English, Mandarin, Cantonese, and Shanghainese.
For more information on World CTX 2016, please visit: http://worldctx.com.
About Synthesis Energy Systems, Inc.
Synthesis Energy Systems (SES) is a Houston-based technology company focused on bringing clean high-value energy to developing countries from low-cost and low-grade coal, biomass and municipal wastes through its proprietary gasification technology based upon U-Gas®, licensed from the Gas Technology Institute. The SES Gasification Technology (SGT) can produce clean, low-cost syngas for power generation, industrial fuel gas, chemicals and transportation fuels, replacing expensive natural gas and LNG based energy. SGT enables Growth With Blue Skies, and greater fuel flexibility for both large-scale and efficient small- to medium-scale operations close to fuel sources. Fuel sources include low-rank, low-cost high ash, high moisture coals, which are significantly cheaper than higher grade coals, many coal waste products, biomass, and municipal waste feedstocks. For more information, please visit: www.synthesisenergy.com.
Contact:
MDC Group
Investor Relations:
David Castaneda
Arsen Mugurdumov
414.351.9758
[email protected]
Media Relations:
Susan Roush
747.222.7012
[email protected]


Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Italy Fines Apple €98.6 Million Over App Store Dominance
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



